Enrich Therapeutics
Enrich Therapeutics: The next-generation, image-based single-cell sorter. Enrich Therapeutics Team: Xueqi Liu Qi Zhao
Read MoreDeMay Bio
DeMay Bio is developing a biologic drug for Rheumatoid Arthritis that leverages a natural human protein to target a novel, but validated, disease mechanism directly in the joints. The new drug is an adjunct therapy, to be used alongside a patient’s immunosuppressant regimen, to achieve better disease control, and to reduce disabling joint pain, tissue…
Read MoreELIV5
ELIV5 Therapeutics aims to develop a new class of antifungal drugs that target a critical step in fungal metabolism required for pathogen survival and virulence. ELIV5 Team: Choukri Ben Mamoun
Read MoreAgamon
Agamon partners with hospitals, structures their textual clinical data using NLP and provides tools & services for a faster, efficient & scalable way to access clinical data & insights. Agamon Team: Rotem Lev-Zwickel
Read MoreBow Therapeutics
Bow Therapeutics is developing isolation of human monoclonal antibodies against Chikungunya Virus Glycoprotein using Single B-cell sorting Technology. Bow Therapeutics Team: George Georgiev Jose Quiroz
Read MoreQlear Chemicals
Qlear Chemicals We develop novel permeabilization and optical clearing reagents for 3D imaging of intact, grossed anatomic pathology samples. Qlear Chemicals Team: Elif Alpoge
Read MoreUnicrobe
We will provide bacterial genome editing services using CRISPR-Cas technologies for academic and industrial customers interested in improving human health and developing bacterial technologies. Team: Wenyan Jiang – CEO, CSO Yuchen Qi – Business Development
Read MoreiLight Biotechnologies
Genetic tools for non-invasive activation and detection of biological processes with deeply penetrating near-infrared light that will make drug discovery process more efficient. iLight Biotechnologies Team: Daria Shcherbakova, PhD. – Co-founder, CEO Vladislav Verkhusha, PhD. – Co-founder, CSO
Read MoreMicrostructure Imaging
We are a service company that improves medical image quality via advanced post-processing and uses this improvement to develop quantitive biomarkers specific to cellular-level pathology. Team: Lieven Nuyttens, CEO Gregory Lemberskiy, CTO
Read MoreGentroma
A portable DNA sequencer that can make finding out information about one’s genetic ancestry, disease risk, and other factors available to the masses, cost-effectively. Team: Krista Fretes, CEO Parth Shah, CTO
Read More